VHL Loss Predicts Response to Aurora Kinase a Inhibitor in Renal Cell Carcinoma Cells

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2018.9038
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

-Catenin Links Von Hippel-Lindau to Aurora Kinase a and Loss of Primary Cilia in Renal Cell Carcinoma

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

MYC Activation Cooperates With VHL and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Insights Into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma

Cancer Discovery
Oncology
2017English

The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls

2012English

High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2012English

The Role of VHL in Clear-Cell Renal Cell Carcinoma and Its Relation to Targeted Therapy

Kidney International
Nephrology
2009English

Clinical Benefit to an Aurora a Kinase Inhibitor in a Patient With Metastatic Integrase Interactor 1‐Deficient Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2018English

Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-response in VHL−/−clear Cell Renal Carcinoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

The Aurora-Kinase a Phe31-Ile Polymorphism as Possible Predictor of Response to Treatment in Head and Neck Squamous Cell Carcinoma

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy